Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sacubitril 24mg / Valsartan 26mg tablets
0205052AEAAACAC
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 89,408 |
|
Sacubitril 97mg / Valsartan 103mg tablets
0205052AEAAABAB
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 82,995 |
|
Sacubitril 49mg / Valsartan 51mg tablets
0205052AEAAAAAA
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 76,127 |
|
Sacubitril 15mg / Valsartan 16mg gran in caps for opening
0205052AEAAAEAE
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 42 |
|
Sacubitril 6mg / Valsartan 6mg gran in caps for opening
0205052AEAAADAD
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 26 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.